Insights into the recruitment of class IIa Histone Deacetylases (HDACs) to the SMRT/NCoR transcriptional repression complex by Hudson, Gregg M. et al.
Insights into the Recruitment of Class IIa Histone
Deacetylases (HDACs) to the SMRT/NCoR Transcriptional
Repression Complex*
Received for publication,April 24, 2015, and in revised form, May 27, 2015 Published, JBC Papers in Press, June 8, 2015, DOI 10.1074/jbc.M115.661058
GreggM. Hudson‡, Peter J. Watson‡, Louise Fairall‡, Andrew G. Jamieson§, and JohnW. R. Schwabe‡1
From the ‡Department of Biochemistry, HenryWellcome Laboratories of Structural Biology, University of Leicester, Leicester
LE1 9HN and the §Department of Chemistry, University of Leicester, Leicester LE1 7RH, United Kingdom
Background: Class IIa histone deacetylases (HDACs) repress transcription through association with the SMRT/NCOR
co-repressor complex.
Results:A repeated peptidemotif mediates recruitment of class IIa HDACs to the co-repressor proteins interacting adjacent to
the active site.
Conclusion: Class IIa HDACs are recruited to co-repressors by a simple repeated peptide motif.
Significance: First insights into the assembly of Class IIa HDACs with repression complexes.
Class IIa histone deacetylases repress transcription of target
genes.However, theirmechanismof action is poorly understood
because they exhibit very low levels of deacetylase activity. The
class IIa HDACs are associated with the SMRT/NCoR repres-
sion complexes and this may, at least in part, account for their
repressive activity. However, the molecular mechanism of
recruitment to co-repressor proteins has yet to be established.
Here we show that a repeated peptide motif present in both
SMRT and NCoR is sufficient to mediate specific interaction,
with micromolar affinity, with all the class IIa HDACs (HDACs
4, 5, 7, and 9). Mutations in the consensus motif abrogate bind-
ing. Mutational analysis of HDAC4 suggests that the peptide
interacts in the vicinity of the active site of the enzyme and
requires the “closed” conformation of the zinc-binding loop on
the surface of the enzyme. Together these findings represent the
first insights into the molecular mechanism of recruitment of
class IIa HDACs to the SMRT/NCoR repression complexes.
The post-translational acetylation of lysine residues plays an
important role in regulating the activity of many proteins (1).
Levels of acetylation are controlled through the opposing
action of acetyltransferase and deacetylase enzymes. These
enzymes were first characterized as a consequence of their role
in regulating gene expression through controlling the acetyla-
tion of lysine residues in the tails of histone proteins. In humans
there are 18 deacetylase enzymes (often called histone deacety-
lases or HDACs),2 which can be grouped into four classes on
the basis of sequence conservation (reviewed in Ref. 2).
The class I HDACs 1–3 are nuclear proteins that play roles in
regulatingmultiple genomic activities including transcriptional
repression, DNA repair, and replication (reviewed in Ref. 3).
Importantly, they require assembly into cognate co-repres-
sor complexes for full activity and genome targeting (4–10).
The structural basis for the interaction of HDACs 1 and 3
with their cognate corepressors MTA1 and SMRT/NCoR
has recently been established. These structures show that
SANT domains in the cognate co-repressor proteins play a
key role in activating the HDACs through mediating inter-
action with inositol phosphates, which are essential for full
deacetylase activity (11, 12).
Class IIa HDACs are also predominantly nuclear proteins,
but, unlike the class I HDACs that consist of a single catalytic
domain, the class IIa HDACs contain an N-terminal extension
of600 residues. This N-terminal domain provides a platform
for several protein-protein interactions and post-translational
modifications (13–15). Importantly, although class IIa HDACs
also act to repress transcription their mechanism of action
appears to be distinct from that of the class I HDACs. In partic-
ular, their transcriptional repression activity may, at least in
part, be independent of the catalytic domain of the deacetylase
(16, 17). Indeed, the catalytic domain itself has a very weak
deacetylase activity, which correlates with a histidine residue,
unique to class IIa HDACs. In the class I enzymes, the equiva-
lent residue is a tyrosine and mutation of the histidine to a
tyrosine greatly increases the activity of the class IIa enzymes
(18–20).
Importantly, like the class I enzymes, the class IIa HDACs 4,
5, and 7 have been shown to interact through their catalytic
domain, with the co-repressors SMRT and NCoR. However,
this interaction does not involve the conserved SANT domain
of the corepressor and has instead been mapped to a region
(repression domain 3 or RD3) that is predicted to be intrinsi-
cally disordered (21–23).
To date we have only limited understanding of the nature of
the interaction between class IIa HDACs and the SMRT/
NCOR co-repressors. Here we show that a conserved and
repeated sequencemotif within the SMRTandNCoR corepres-
sors directlymediates interactionwith all four class IIaHDACs.
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We also show that mutations around the active site of HDAC4,
as well as the binding of HDAC inhibitors modulate the inter-
action with co-repressors.
Experimental Procedures
Preparation of Recombinant HDAC4—Histone deacetylase 4
was expressedwith a hexa-histidine tag, S-tag, and tobacco etch
virus protease cleavage site at the N terminus using a pET30
expression vector in the Rosetta strain ofEscherichia coli (Invit-
rogen). Cells were grown in 2YT medium supplemented with
34g/ml of chloramphenicol and 50g/ml of kanamycin. Cells
were grown at 37 ºC to an A600 0.8–1.0 before being supple-
mented with 50 M zinc acetate for 30 min prior to induction
with 40 M isopropyl -D-thiogalactopyranoside then grown
for 16 h at 18 ºC. Cells were harvested by centrifugation at
5000 g and resuspended in lysis buffer (25mMHEPES, pH7.5,
200 mM potassium chloride, 30% glycerol, 1 mM dithiothreitol,
and a complete EDTA-free protease inhibitor tablet (Roche
Applied Sciences)). 20 mM magnesium chloride and 100 l of
10 mg/ml of DNase I (Sigma) was added to the suspended cells
prior to lysis using a C3-EmulsiFlex (Avastin Inc.) at 22,500
p.s.i. Lysates were clarified by ultracentrifugation (110,000 g,
25 min, 4 ºC) before binding to pre-equilibrated Ni-NTA resin
(Qiagen) for 30 min. HDAC4 was diluted with an equal volume
of dilution buffer (25 mM HEPES, pH 7.5, 200 mM potassium
chloride, and 1mMdithiothreitol) prior to binding to resin. The
resin was extensively washed with wash buffer (25 mM HEPES,
pH 7.5, 200 mM potassium chloride, 5% glycerol, 1 mM dithio-
threitol, and 20mM imidazole, pH 8.0). HDAC4was elutedwith
6 volumes of elution buffer (25 mM HEPES, pH 7.5, 200 mM
potassium chloride, 5% glycerol, 1 mM dithiothreitol, and 150
mM imidazole, pH 8.0). Protein was dialyzed at 4 ºC overnight
(25 mM HEPES, pH 7.5, 20 mM potassium chloride, 10% glyc-
erol, and 1mM dithiothreitol). The protein was further purified
on a HiTrapQ ion exchange column (GE Healthcare) at 4 ºC
against a salt gradient (25 mM HEPES, pH 7.5, 50–500 mM
potassium chloride, 1 mM dithiothreitol). The protein was
cleaved with tobacco etch virus protease at 4 ºC overnight
before a final purification using a Superdex S200 column at 4 ºC
(25mMHEPES, pH7.5, 200mMpotassiumchloride, 1mMdithi-
othreitol). HDAC4was concentrated using Amicon centrifugal
concentrators before use.
Preparation of Recombinant HDAC7—Histone deacetylase 7
was prepared in the samemanner toHDAC4, however, the high
speed supernatant of HDAC7 was not diluted prior to incu-
bation with Ni-NTA resin and the following buffers were
used. Lysis buffer was 1 PBS, pH 7.4, 500 mM sodium chlo-
ride, 5% glycerol, 0.1% CHAPS, 1 mM dithiothreitol, 25
g/ml of 4-(2-aminoethyl)benzenesulfonyl fluoride and a
complete EDTA-free protease inhibitor tablet. Wash buffer
was 20 mM Tris, pH 8.0, 250 mM sodium chloride, 0.1%
CHAPS, 1 mM dithiothreitol, and 20 mM imidazole, pH 8.0.
Elution buffer was 20 mM Tris, pH 8.0, 250 mM sodium chlo-
ride, 0.1% CHAPS, 1 mM dithiothreitol, and 250 mM imidaz-
ole pH 8.0. Dialysis buffer was 20 mM Tris, pH 8.0, 150 mM
sodium chloride, 5% glycerol, and 1 mM dithiothreitol. Ion
exchange buffer was 20 mM Tris, pH 8.0, 50–500 mM sodium
chloride. Gel filtration buffer was 20 mM Tris, pH 8.0, 100
mM sodium chloride.
Preparation of Recombinant HDACs 5 and 9—Histone
deacetylases 5 and 9 were prepared in the same manner to
HDAC4, however, the high speed supernatants were not
diluted prior to incubation with Ni-NTA resin and the follow-
ing buffers were used. Lysis buffer was 45 mM Tris, pH 8.0, 120
mM sodium chloride, 2.5 mM potassium chloride, 15% glycerol,
1 mM dithiothreitol and a complete EDTA-free protease inhib-
itor tablet.Wash bufferwas 45mMTris, pH8.0, 120mM sodium
chloride, 2.5 mM potassium chloride, 10% glycerol, 1 mM dithi-
othreitol, and 20 mM imidazole, pH 8.0. Elution buffer was 45
mM Tris, pH 8.0, 120 mM sodium chloride, 2.5 mM potassium
chloride, 10% glycerol, 1 mM dithiothreitol, and 200 mM imid-
azole pH 8.0. Dialysis buffer was 45 mM Tris, pH 8.0, 50 mM
sodium chloride, 2.5 mM potassium chloride, 10% glycerol and
1 mM dithiothreitol. Ion exchange buffer was 45 mM Tris, pH
8.0, 50–500mM sodium chloride, 2.5 mM potassium chloride, 1
mM dithiothreitol. Gel filtration buffer was 45 mM Tris, pH 8.0,
120 mM sodium chloride, 2.5 mM potassium chloride, 1 mM
dithiothreitol.
Peptide Production—Wild type peptide was obtained from
Biomatik. Mutant peptides were synthesized in house using a
CEM microwave peptide synthesizer. Peptides for use in fluo-
rescence anisotropy assays were synthesized with an extra
N-terminal cysteine.
Fluorescence Anisotropy—Peptides were coupled to
BODIPY-TMR by incubation in 18 M water at a 5:1 molar
ratio for 2 h at room temperature with continual stirring. Fol-
lowing incubation, buffer was exchanged into 1 PBS, 0.5 mM
Tris(2-carboxyethyl)phosphine using a PD-10 column (GE
Healthcare). Labeled peptides were concentrated using an
Amiconcentrifugal concentrator. Immediatelyprior to the fluo-
rescence anisotropy assays the HDACs were concentrated and
buffer exchanged into 1 PBS, 0.5 mM Tris(2-carboxyethyl)-
phosphine and the protein concentration was determined by
A280 in 6 M guanidine HCl. Protein was dispensed into 96-well
black plates prior to a 2-fold serial dilution in reaction buffer
(1 PBS, 0.01% Triton X-100, 0.1 mg/ml of BSA). Inhibitors
were preincubated with HDACs for 30 min at a 2:1 ratio before
serial dilution. Labeled peptide was added to a final concentra-
tion of 1 M in a 50-l reaction volume. Measurements were
recorded using an excitation wavelength of 531 nm and emis-
sion wavelength of 595 nm. Data were analyzed using
GraphPad Prism, assuming non-linear fit with one-site binding
to fulfill the equation y Bmax x/(Kd x).
Histone Deacetylase Activity Assays—A fluorescent HDAC
assay (ActiveMotif)was used to determineHDACactivity. Pro-
tein was diluted to the desired concentration in assay buffer (20
mM Tris, pH 7.5, 0.25 mM EDTA, 250 mM sodium chloride)
before incubation for 90min at 37 ºC with 100MBOC-acetyl-
lysine substrate. The assay was terminated by incubation with
developer solution (2 M trichostatin A, 10 g/l of trypsin, 50
mM Tris, pH 7.5, 100 mM sodium chloride) for 10 min at 25 ºC.
Measurements were recorded using an excitation wavelength
of 355 nm and an emission wavelength of 460 nm.
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Results
Identification of a Consensus GSI Motif in RD3 of SMRT/
NCoR—The so-called repression domain 3 (RD3) of SMRT and
NCoR has previously been shown to interact both with the
repressive transcription factor BCL6 and with the class IIa
HDACs (16, 21–23). Sequence analysis of the RD3 regions of
SMRT and NCoR indicates that these regions are intrinsically
unstructured. Strikingly, within theRD3domain, we observed a
repeated 8-amino acid motif with a consensus sequence G-S-I-
t/s-q-G-t-P (capitals indicate absolute conservation). In SMRT
and NCoR there are 5 and 6 GSI motifs, respectively, with an
apparent core conserved region consisting of 4 motifs flanking
the BCL6 binding domain (Fig. 1A). Alignment of 70 GSI
motifs and the flanking regions from multiple SMRT/NCoR
homologues suggests that the sequence conservation is
restricted to the core eight amino acids (Fig. 1B) suggesting an
important functional role for this motif. Interestingly a scan
prosite search using GSI(S/T)XGXP as a search pattern indi-
cates that this motif is not found in any other proteins in the
human proteome. We hypothesized therefore that these GSI
motifs might play a role in mediating interaction of co-repres-
sor proteins with the class IIa HDACs.
Interaction of GSI Motifs with Class IIa HDACs—To deter-
mine whether GSI motifs do indeed mediate interaction with
class IIa HDACs we synthesized a peptide corresponding to
amino acids 1450–1469 from the SMRT, which contains a per-
fect GSITQGTP consensus motif and an amino-terminal cys-
teine. The cysteine was chemically coupled to a BODIPY fluo-
rophore. Fluorescence anisotropy measurements using the
labeled peptide and bacterially expressed HDAC4 indicated a
saturable interaction with a low micromolar dissociation con-
stant similar to that of other protein-protein interactions
involving the co-repressor complexes (24–26) (Fig. 2A).
To explore the sequence dependence of the interaction with
HDAC4 we synthesized 12 peptides in which the GSITQGTP
sequence was systematically altered (Fig. 2A). Strikingly, even
conservative mutations in Gly-1, Ser-2, Ile-3, Gly-6, and Thr-7
essentially completely abolished interaction with HDAC4 sug-
gesting that these side chains are involved in stereospecific
interactions with the catalytic domain of theHDAC.Mutations
to Thr-4, Gln-5, and Pro-8 did not reduce binding to the same
extent suggesting that these residues are less important for the
interaction. The lower conservation of the amino acid in posi-
tion 5 fits well with this finding. In contrast, nearly 90% of the
GSI motifs have a threonine or serine at position 4. This sug-
gests that the hydroxyl group shared by these residues is impor-
tant in some way, even though it is not required for interaction
with HDAC4.
To determine whether other class IIa HDACs can also be
recruited to the SMRT/NCoR corepressors through the GSI
motif, we purified the recombinant catalytic domains of
HDACs 4, 5, 7, and 9, along with full-length HDAC8 as an
intrinsically active class IHDACcontrol (27). Fluorescence ani-
sotropy assays clearly show that all four class IIa HDACs can
interact with the GSI motif peptide with similar binding affini-
ties (Fig. 2B). The class I HDAC8 shows no interaction with the
peptide supporting the hypothesis that the GSI motif interac-
tion is specific to class IIa HDACs.
Insights into the Interaction of GSI Peptides with HDAC4—
To understand the nature of the interaction of GSI motifs with
HDAC4 we set up many crystallization trials of the complex,
but were ultimately unsuccessful in obtaining diffraction qual-
FIGURE 1.A repeated sequencemotifwithin the class IIaHDACbinding regionof SMRT/NCORco-repressors.A,domain arrangement of SMRT indicating
regions known to interact with partner proteins and schematic of RD3 of SMRT/NCoR showing the location of identified GSI repeats and the BCL6 binding
domain with a similar arrangement and spacing. B,Weblogo plot of RD3 GSI motifs from SMRT and NCoR of 6 species demonstrates a well conserved 8 amino
acid residue motif. NR, nuclear receptor binding region.
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ity crystals. However, it has previously been reported that the
presence of an HDAC inhibitor may influence the interaction
between HDAC4 and the co-repressors complexes suggesting
that there may be cross-talk between the active site and the
co-repressor interaction interface (19, 20, 28).
Importantly, structural studies of HDAC4 have shown that
two structured loops (amino acids 669–679 and 729–765) can
adopt very different configurations in different structures (Fig.
3,A and B) (20). In the so-called “closed conformation” (seen in
the structure of the H976Y gain-of-function mutation (20)) the
two loops collaborate to form a tetrahedral zinc-binding site
with three cysteines (Cys-667, Cys-669, and Cys-751) and one
histidine (His-675). It has been suggested that inhibitor binding
influences the conformation of these loops and favors an “open
conformation” in which two of the zinc ligands are substituted
(Cys-669 and His-675 substituted by His-678 and His-665,
respectively (20)).Wehypothesized that the co-repressor inter-
action surface may involve these surface loops, which are in
proximity to the active site of the enzyme.
To test this we mutated 3 of the ligands for the zinc in the
closed conformation (Cys-667,His-675, andCys-751) (Fig. 3A).
Strikinglywe found that all threemutations abolished the inter-
action of HDAC4with the GSI peptide strongly suggesting that
the corepressor interface lies in the vicinity of these loops and
requires the closed conformation of the surface loops (Fig. 3C).
Interestingly the mutation of leucine 728 to alanine has also
been shown to favor the closed conformation of the loops (29).
We show that this mutation binds GSI peptides with the same
affinity as the wild type enzyme.
To explore further whether there is communication between
the GSI binding surface and the active site, we tested whether
differentHDAC inhibitors influenced the binding affinity of the
GSI peptides to both wild type and H976Y gain-of-function
HDAC4. Both proteins were incubated with a 2-fold molar
excess of four HDAC inhibitors, suberoylanilide hydroxamic
acid, trichostatin A, valproic acid, and sodium butyrate (Fig.
4A). Interestingly the gain-of-function mutant interacted with
significantly higher affinity than the wild type supporting the
hypothesis that GSI peptide binding is favored by the closed
conformation of the enzyme. The four inhibitors did not greatly
affect the affinity of GSI peptide binding to the wild type
enzyme although the inhibitors that are large enough to pro-
trude from the active site pocket (Fig. 4B), trichostatin A and
suberoylanilide hydroxamic acid, gave a lowermaximumpolar-
ization suggesting that the character of the inhibitor can
directly or indirectly influence the mobility of the fluorophore
attached to the GSI peptide. These larger inhibitors bound to
the gain-of-function mutant result in significantly decreased
affinity for the GSI peptide. Again this suggests cross-talk
between the active site of HDAC4 and the co-repressor inter-
action surface. This raises the interesting possibility that co-re-
pressor binding might play a role in activating the class IIa
HDACs.
FIGURE 2. Investigating the interaction between class IIa HDACs and aGSImotif peptide (CPRPLKEGSITQGTPLKYDTG). A, a peptide representative of a
wild type GSI motif and 12mutant peptides were fluorescently labeled for use in fluorescence anisotropy to define and characterize the interaction between
the peptide and HDAC4. B, fluorescence anisotropy was performed using the wild type peptide with the catalytic domains of class IIa HDACs HDAC4, HDAC5,
HDAC7, and HDAC9 and the class I HDAC8.
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Corepressor Interactions Do Not Appear to Enhance the
Deacetylase Activity of Class IIa HDACs—The class I HDACs
1–3 are reliant upon their interaction with cognate co-repres-
sor complexes to attain maximum activity. Because class IIa
HDACs are generally thought to be inactive enzymes, we
sought to investigate whether interaction with the co-repressor
GSImotifmight activate these enzymes in an analogous fashion
to the class I HDACs. HDAC activity assays were used to deter-
mine whether the presence of an excess of the GSI motif pep-
tide could enhance the activity of 5 M HDAC4. Importantly,
the presence of the GSI peptide appeared to have no effect on
the lysine deacetylase activity of the HDAC4 catalytic domain
(Fig. 5).
Discussion
Themolecular functioning of the vertebrate class IIaHDACs
remains an enigma. They have a catalytic domain conserved
back to yeast, which is homologous to the better understood
class I HDACs. However, in the vertebrate class IIa enzymes a
key amino acid at the active site is a histidine rather than the
tyrosine that is essential for potent deacetylase activity (19).
Thus these enzymes have a very low intrinsic lysine deacetylase
activity. However, the active site is otherwise complete because
mutagenesis of the histidine to a tyrosine restores a high level of
deacetylase activity (19, 20). There are three possible interpre-
tations: (i) the class IIa HDACs are not enzymatically active; (ii)
they are activated by some unknown mechanism; or (iii) they
have a different, but as yet unknown, enzymatic activity.
The concept that these enzymes might be activated in some
way is particularly attractive because the class I HDACs 1–3 are
known to be activated through assembly into co-repressor
complexes and this activation requires the presence of inositol
phosphates bound at the HDAC:corepressor interface (11, 12).
If a similar scenariowere to be true for the class IIaHDACs then
it becomes important to understand how these are assembled
into corepressor complexes.
In this studywe have explored the recruitment of the class IIa
HDACs to the SMRT/NCoR corepressor proteins. We show
that class IIa HDACs interact specifically with RD3 of the
SMRT/NCOR co-repressor complexes through an 8-amino
acid GSI motif of which there are multiple occurrences of in
each co-repressor. Although a single copy of the GSI motif is
sufficient for a measurable interaction, it seems likely that the
FIGURE 3. Comparison of the closed (A) and open (B) loop conformations of HDAC4. Views of a wild type HDAC4 structure (Protein Data Bank code 2vqj)
with anopen loop conformation (cyan) and an L728Amutant structure (ProteinData Bank code4cby),whichdemonstrates a closed loop conformation (green).
Side chains of the residues discussed in the text are highlighted inmagenta. Zinc atoms are colored yellow. C, fluorescence anisotropy binding experiments of
GSI peptide to wild type HDAC4cd, L728A mutant, which is reported to stabilize the class IIa loop, and three mutants of the zinc chelating residues, C667A,
H675A, and C751A.
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multiple copies increase the local concentration of the motif so
as to increase the avidity and hence the likelihood of recruit-
ment. We would suggest that it is less likely that the repeated
GSI motifs facilitate the recruitment of multiple class IIa
HDACs.
Ourmutagenesis studies suggest that the GSImotifs interact
in the vicinity of the active site of the class IIa HDACs and
require the class IIa specific loop to adopt the so-called “closed”
configuration. There appears to be communication between
the active site and the stability of this loop because the binding
of larger HDAC inhibitors both disfavors corepressor binding
and appear to favor the open (or disordered) configuration of
this loop. The importance of the loop configuration for core-
pressor binding is supported by the finding that the histidine to
tyrosine gain-of-function mutation both favors the closed con-
figuration of the loop and binds the GSI peptides more tightly.
It is unclear as to whether there are any native mechanisms
that control a transition between the open and closed confor-
mation of this loop, whichmay provide a regulatory process for
the co-repressor interaction. However, it has been reported
that reduction of one of the zinc chelating cysteines (Cys-669)
by thioredoxin I alters the function of HDAC4 and prevents
nuclear export (30). It is possible that this reduction promotes
the loop to adopt the open conformation, which would also
result in a loss of co-repressor interaction.
In contrast to the class I HDACs, the class IIa HDACs do not
show any significant enhancement of lysine deacetylase activity
when bound to the corepressor. Therefore, the role of class IIa
HDACs in the SMRT/NCoR repression complex remains to be
determined. It should not be forgotten that these enzymes all
have an extensive amino-terminal domain that is likely to play a
role in gene regulation.
Understanding the mechanism of action of the class IIa
HDACs is important becausemultiple lines of evidence suggest
that they are associated with human disease. Indeed, a mouse
model of Huntington disease is alleviated when the levels of
HDAC4 are reduced (31). Loss of HDAC5 impairs memory
function (32). HDAC7 promotes apoptosis and c-Myc regula-
tion in some leukemias and lymphomas, which may partly be
due to the fact that it is a substrate for the extrinsic apoptosis
protein caspase 8 (33, 34). Furthermore, a genome wide associ-
ation study has identified a variant HDAC9 that is associated
with large vessel ischemic stroke (35).
FIGURE 4. Investigating the effect of inhibitors on theHDAC4-GSI interaction.A, fluorescence anisotropy ofwild type (WT) and theH976Ygain-of-function
(GOF) HDAC4 catalytic domainwith 2-foldmolar excess of different HDAC inhibitors. B, schematic representation of how the different HDAC inhibitors occupy
the active site.
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